KY-556
CAS: 110816-78-9
Ref. 3D-KEA81678
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- 1,3-Bis-(2-ethoxycarbonylchromon-5-yloxy)-2-(lysyloxy)propane
- Ky 556
- L-Lysine, 2-((2-(ethoxycarbonyl)-4-oxo-4H-1-benzopyran-5-yl)oxy)-1-(((2-(ethoxycarbonyl)-4-oxo-4H-1-benzopyran-5-yl)oxy)methyl)ethyl ester, dihydrochloride
- diethyl 5,5'-{[2-(L-lysyloxy)propane-1,3-diyl]bis(oxy)}bis(4-oxo-4H-chromene-2-carboxylate) dihydrochloride
KY-556 is a peptide inhibitor of the Kv1.2 voltage-gated potassium channel. It is a potent and selective blocker of Kv1.2 channels, with an IC50 of 0.4 μM and no activity against other voltage-gated potassium channels (Kv1.1, 1.3, 1.6). KY-556 has been shown to inhibit the proliferation of tumor cells by blocking Kv1.2 channels in cell culture experiments and in vivo in mice with implanted melanoma tumors. KY-556 also inhibits the release of inflammatory cytokines such as IL-6 and TNFα from human monocytes and macrophages, suggesting that it may have anti-inflammatory properties as well as tumor suppression capabilities.
KY-556 is synthesized using solid phase peptide synthesis on a Rink amide resin with an N-terminal lysine side chain protecting group and a COOH terminus acid side chain protecting group.
Propiedades químicas
Consulta técnica sobre: 3D-KEA81678 KY-556
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
